Huron Regional Medical Ctr is a medicare approved dialysis facility center in Huron, South Dakota and it has 7 dialysis stations. It is located in Beadle county at 172 4th St Se, Huron, SD, 57350. You can reach out to the office of Huron Regional Medical Ctr at (605) 353-6518. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Huron Regional Medical Ctr has the following ownership type - Non-Profit. It was first certified by medicare in August, 1977. The medicare id for this facility is 430011 and it accepts patients under medicare ESRD program.
| Name | Huron Regional Medical Ctr |
|---|---|
| Location | 172 4th St Se, Huron, South Dakota |
| No. of Dialysis Stations | 7 |
| Medicare ID | 430011 |
| Managed By | Independent |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 172 4th St Se, Huron, South Dakota, 57350 | |
| (605) 353-6518 | |
News Archive
USAID announces $5 million award to support the development of a global network to track avian influenza, with the aim of monitoring the role of migratory birds.
Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.
Lysosomes are filled with more than 50 different hydrolytic enzymes, which are capable of digesting most cellular components.
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
› Verified 7 days ago
| NPI Number | 1568582013 |
| Doing Business As | Huron Regional Medical Center Inc |
| Address | 172 4th St Se Huron, South Dakota, 57350 |
| Phone Number | (605) 353-6200 |
News Archive
USAID announces $5 million award to support the development of a global network to track avian influenza, with the aim of monitoring the role of migratory birds.
Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.
Lysosomes are filled with more than 50 different hydrolytic enzymes, which are capable of digesting most cellular components.
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
› Verified 7 days ago
| Dialysis patients with Hemoglobin data | 13 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 8 |
News Archive
USAID announces $5 million award to support the development of a global network to track avian influenza, with the aim of monitoring the role of migratory birds.
Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.
Lysosomes are filled with more than 50 different hydrolytic enzymes, which are capable of digesting most cellular components.
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 20 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 177 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
USAID announces $5 million award to support the development of a global network to track avian influenza, with the aim of monitoring the role of migratory birds.
Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.
Lysosomes are filled with more than 50 different hydrolytic enzymes, which are capable of digesting most cellular components.
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Huron Regional Medical Ctr with elevated calcium levels.
| Patients with hypercalcemia | 20 |
| Hypercalcemia patient months | 178 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 22 |
| Patients with Serumphosphor less than 3.5 mg/dL | 7 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 38 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
| Patients with Serumphosphor greater than 7 mg/dL | 10 |
News Archive
USAID announces $5 million award to support the development of a global network to track avian influenza, with the aim of monitoring the role of migratory birds.
Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.
Lysosomes are filled with more than 50 different hydrolytic enzymes, which are capable of digesting most cellular components.
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 19 |
| Patient months included in arterial venous fistula and catheter summaries | 154 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 79 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 12 |
News Archive
USAID announces $5 million award to support the development of a global network to track avian influenza, with the aim of monitoring the role of migratory birds.
Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.
Lysosomes are filled with more than 50 different hydrolytic enzymes, which are capable of digesting most cellular components.
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
› Verified 7 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 15 |
| Hospitalization Rate in facility | 96.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 347.7 |
| Hospitalization Rate: Lower Confidence Limit | 29.4 |
News Archive
USAID announces $5 million award to support the development of a global network to track avian influenza, with the aim of monitoring the role of migratory birds.
Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.
Lysosomes are filled with more than 50 different hydrolytic enzymes, which are capable of digesting most cellular components.
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
› Verified 7 days ago
The rate of readmission show you whether patients who were being treated regularly at Huron Regional Medical Ctr were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 23.5 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 53.1 |
| Readmission Rate: Lower Confidence Limit | 5.6 |
News Archive
USAID announces $5 million award to support the development of a global network to track avian influenza, with the aim of monitoring the role of migratory birds.
Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.
Lysosomes are filled with more than 50 different hydrolytic enzymes, which are capable of digesting most cellular components.
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
› Verified 7 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Huron Regional Medical Ctr get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .57 (As Expected) |
| SIR: Upper Confidence Limit | 2.8 |
| SIR: Lower Confidence Limit | .03 |
News Archive
USAID announces $5 million award to support the development of a global network to track avian influenza, with the aim of monitoring the role of migratory birds.
Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.
Lysosomes are filled with more than 50 different hydrolytic enzymes, which are capable of digesting most cellular components.
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
› Verified 7 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Huron Regional Medical Ctr's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 12 |
| Transfusion Rate in facility | (Not Available) |
| Transfusion Rate: Upper Confidence Limit | |
| Transfusion Rate: Lower Confidence Limit |
News Archive
USAID announces $5 million award to support the development of a global network to track avian influenza, with the aim of monitoring the role of migratory birds.
Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.
Lysosomes are filled with more than 50 different hydrolytic enzymes, which are capable of digesting most cellular components.
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
› Verified 7 days ago
The rate of mortality show you whether patients who were being treated regularly at Huron Regional Medical Ctr lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 93 |
| Mortality Rate in facility | 18.6 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 29.5 |
| Mortality Rate: Lower Confidence Limit | 11.1 |
News Archive
USAID announces $5 million award to support the development of a global network to track avian influenza, with the aim of monitoring the role of migratory birds.
Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.
Lysosomes are filled with more than 50 different hydrolytic enzymes, which are capable of digesting most cellular components.
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
› Verified 7 days ago
News Archive
USAID announces $5 million award to support the development of a global network to track avian influenza, with the aim of monitoring the role of migratory birds.
Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.
Lysosomes are filled with more than 50 different hydrolytic enzymes, which are capable of digesting most cellular components.
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
› Verified 7 days ago